InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the complete record of transactions filed by Deignan Charles A., Chief Financial Officer. Officer active across 1 companies, notably Clearside Biomedical, Inc.. Aggregated, 8 filings have been logged. Total volume traded: €52k. The latest transaction was filed on 18 January 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations8 total
046,250 shares0
Common Stock
SEC:0001209191-22-005437·
046,250 shares0
Common Stock
SEC:0001209191-22-005437:0·
043,750 shares0
Common Stock
SEC:0001209191-22-004194·
043,750 shares0
Common Stock
SEC:0001209191-22-004194:0·
€15,3102,800 shares@ €5.46790.021% mcap58.7% of flow
Common Stock
SEC:0001209191-21-057457·
€15,3102,800 shares@ €5.46790.021% mcap29.3% of flow
Common Stock
SEC:0001209191-21-057457:0·
€10,7782,938 shares@ €3.66840.015% mcap41.3% of flow
Common Stock
SEC:0001209191-21-042803·
€10,7782,938 shares@ €3.66840.015% mcap20.7% of flow
Common Stock
SEC:0001209191-21-042803:0·
8 of 8 declarations
About Deignan Charles A.
Charles A. Deignan is the Chief Financial Officer of Clearside Biomedical, Inc. In this role, he is responsible for financial management and strategy for the company. Clearside Biomedical, Inc. is committed to developing treatments for eye diseases. Charles plays a key role in financial planning and analysis.
